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Clinical and Pathological Findings of a Korean Family 
with Pathogenic Variants of the TTN Gene
Dear Editor,
Titinopathies are a group of clinical and pathologically heterogeneous muscle disorders. 
These diseases have been frequently reported in the Finnish population, but have been 
rarely found in Asian populations.1 We previously reported recessive TTN variants as the 
genetic cause in a large Korean cohort of inherited muscular disorders.2 However, the de-
tailed clinical phenotype was not investigated. Here we present clinical and pathological 
findings of a Korean family with rigid spine syndrome and respiratory difficulty carrying 
pathogenic variants of TTN.
The proband (a 43-year-old man) (Fig. 1A and B, II-5) complained of muscle weakness, 
scoliosis, and respiratory difficulty. He demonstrated muscle weakness, faint crying, and 
weak sucking at birth. Since childhood he had experienced difficulty in bending his neck 
and spine. He was first hospitalized at the age of 30 years for respiratory difficulty, since 
when he used noninvasive positive pressure ventilation via a nasal mask intermittently, 
mainly at nighttime. When we examined him at the age of 43 years, he could walk indepen-
dently. He displayed proximal weakness, lordosis, scoliosis, ankle contracture, and limited 
bending of the neck (Fig. 1C). He did not have extraocular movement limitation or cranio-
facial dysmorphism. His forced vital capacity was 0.76 L (20%), his PaCO2 was 47.4 mm 
Hg, and his serum creatine kinase level was 89 IU/L (reference value <185 IU/L). The elec-
tromyography findings were compatible with chronic myopathy, while his electrocardiogra-
phy and echocardiography findings were normal. A biceps brachii muscle biopsy was per-
formed when he was 30 years old. Staining with hematoxylin and eosin revealed moderate 
variations of fiber size and shape, in addition to many fibers having internalized nuclei (Fig. 
1D). Intracytoplasmic inclusions and subsarcolemmal depositions were not found by modi-
fied Gomori trichrome staining (Fig. 1E). Staining with nicotinamide adenine dinucleotide-
tetrazolium reductase revealed that type I fibers predominated (Fig. 1F). The older sister of 
the proband (a 50-year-old woman) (Fig. 1A and B, II-2) had a similar clinical presentation 
that included proximal weakness, lordosis, scoliosis, ankle contracture, and limited bending 
of the neck. Although she did not use a ventilator, she experienced morning headaches and 
daytime somnolence. Her forced vital capacity was 0.8 L (22%) and she exhibited limited 
extraocular movement.
We performed targeted sequencing of 69 myopathy-related genes, including TTN, to ob-
tain a confirmative diagnosis in the proband (Supplementary Table 1, 2, and 3 in the online-
only Data Supplement). We identified two compound heterozygous TTN variants: c. 14372-
2A>G and c.102523C>T (Fig. 1B) (Supplementary Information in the online-only Data 
Supplement). Capillary sequencing showed that the TTN variants cosegregated completely 
with the two affected family members (Fig. 1A and B). The c.14372-2A>G variant has pre-
viously been reported as a pathogenic variant,3 while the c.102523C>T (p.Arg34175*) vari-
ant is a novel truncating variant that was not found in 298 healthy controls, the dbSNP138 
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database, or the 1,000 Genomes Database.
Titin, the protein encoded by TTN, is the largest human 
protein and the third most common type of filament in both 
cardiac and skeletal human muscle. Titin connects the Z-line 
to the M-line and interacts with many other proteins, includ-
ing actin, myosin, nebulin, α-actinin, telethonin, tropomyo-
sin, and calpain-3. However, the pathomechanism of titinop-
athy is unclear. Both dominant-negative and loss-of-function 
Fig. 1. Pedigree, sequencing chromatograms, whole-spine X-ray images, and pathology results. A: Pedigree of a Korean patient with compound 
heterozygous pathogenic variants of TTN. Arrows indicate the proband (square: male; circle: female; filled: affected; unfilled: unaffected). B: Se-
quencing chromatograms of the c.14372-2A>G and c.102523C>T (p.Arg34175*) TTN variants. Arrows indicate pathogenic or likely pathogenic 
variant sites. C: Whole-spine X-ray images. D, E, and F: Histopathology of the biceps brachii. D: Hematoxylin and eosin (H&E) staining of biceps 
brachii muscle tissue revealing moderate variations of fiber size and shape in addition to many fibers having internalized nuclei. E: Intracytoplas-
mic inclusions and subsarcolemmal depositions were not found in modified Gomori trichrome (GT) staining. F: Staining with nicotinamide adenine 
dinucleotide-tetrazolium reductase (NADH-tr) demonstrated the predominance of type I fibers (approximately 84%). (D: H&E stain, ×200; E: mod-
ified GT stain, ×200; F: NADH-tr stain, ×100).

















118  J Clin Neurol 2017;13(1):116-118
TTN Mutations in Rigid Spine SyndromeJCN
mechanisms have been described as underlying titinopathy. 
Actually, titinopathies have highly variable clinical presenta-
tions, including dilated cardiomyopathy, tibial muscular dys-
trophy, limb-girdle muscular dystrophy type 2J, hereditary 
myopathy with early respiratory failure, and centronuclear 
myopathy.4 The skeletal muscle diseases associated with titi-
nopathy have mainly been associated with an autosomal-
dominant late-onset distal myopathy. However, centronucle-
ar myopathy has only been reported as a recessive disease. 
The present family with TTN variants demonstrated rigid 
spine syndrome and respiratory difficulty associated pre-
dominantly with muscle fibers with internalized nuclei, 
which is compatible with a previous report.3
In conclusion, this is the first report of the clinical and patho-
logical features of a Korean family with recessive TTN variants.
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